RAD in stable lung and heart/lung transplant recipients: safety, tolerability, pharmacokinetics, and impact of cystic fibrosis

This publication has 14 references indexed in Scilit:

• Prevention of small airway obliteration in a swine heterotopic lung allograft model
  The Journal of Heart and Lung Transplantation, 2000
• Entry‐into‐human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients
  British Journal of Clinical Pharmacology, 1999
• A PHASE I STUDY OF A 4-WEEK COURSE OF SDZ-RAD (RAD) IN QUIESCENT CYCLOSPORINE-PREDNISONE-TREATED RENAL TRANSPLANT RECIPIENTS1,2
  Transplantation, 1999
• Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine
  The Journal of Heart and Lung Transplantation, 1999
• The macrolide SDZ RAD is efficacious in a nonhuman primate model of allotransplantation
  Transplantation Proceedings, 1998
• Effect of SDZ RAD on transplant arteriosclerosis in the rat aortic model
  Transplantation Proceedings, 1998
• Effects of rapamycin analogue SDZ RAD on obliterative lesions in a porcine heterotopic bronchial allograft model
  Transplantation Proceedings, 1998
• Drug Disposition in Cystic Fibrosis
  Clinical Pharmacokinetics, 1998
• SDZ RAD, A NEW RAPAMYCIN DERIVATIVE
  Transplantation, 1997
• SDZ RAD, A NEW RAPAMYCIN DERIVATIVE
  Transplantation, 1997